Gina Hope, MD
Family Medicine · Wesley Chapel, FLNPI 1205038411
Payments from drug & device makers
Across 85 payments — averaging $160.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$12K
- Novo Nordisk$302
- Pfizer$267
- Novartis$167
- Dexcom, Inc.$118
- AstraZeneca$87
- plus $358 from 14 others
What the payments were for
- Consulting fees$7355%
- Speaking & faculty fees$11,29083%
- Travel & lodging$2112%
- Food & beverage$1,42910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 18 | $12,366 |
| Novo Nordisk | 16 | $302 |
| Pfizer | 17 | $267 |
| Novartis | 10 | $167 |
| Dexcom, Inc. | 2 | $118 |
| AstraZeneca | 1 | $87 |
| Sanofi-aventis U.S. LLC | 3 | $67 |
| Abbott | 2 | $43 |
| Lucid Diagnostics Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $34 |
| Amgen | 2 | $34 |
| AbbVie | 2 | $30 |
| Shionogi Inc | 1 | $15 |
| GSK | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| Bayer | 1 | $14 |
| Neurelis, Inc. | 1 | $14 |
| Melinta Therapeutics, LLC | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GARDASIL 9$11,290
- GARDASIL$211
How this compares
$13,666 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 25 | $381 |
| Bupropion XlBupropion Hcl | 11 | $335 |
| Fluticasone Propionate | 13 | $308 |
| Gabapentin | 19 | $263 |
| Atorvastatin Calcium | 41 | $256 |
| Potassium Chloride | 27 | $242 |
| Levothyroxine Sodium | 46 | $172 |
| Alprazolam | 27 | $161 |
| Amlodipine Besylate | 42 | $147 |
| Rosuvastatin Calcium | 22 | $129 |
| Simvastatin | 14 | $88 |
| Lisinopril | 20 | $73 |
| Losartan Potassium | 11 | $53 |
| Pantoprazole Sodium | 11 | $45 |
| Furosemide | 11 | $28 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Wesley Chapel
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.